MAP Pharmaceuticals (NASDAQ:MAPP.DL)

CAPS Rating: No stars

Pharmaceutical Preparations

Recs

0
Player Avatar TMFBiologyFool (95.97) Submitted: 3/23/2012 2:54:30 PM : Outperform Start Price: $16.10 MAPP.DL Score: +46.26

Still risky, but it looks like an approval is more likely than not.

Featured Broker Partners


Advertisement